Acute myeloid leukemia (AML) is a rapidly progressing blood cancer marked by the abnormal proliferation of immature myeloid cells in the bone marrow and bloodstream. In the United States, growing awareness of AML, advances in diagnostic technologies, and improvements in oncology care are strengthening the focus on early and accurate disease identification. Healthcare providers are increasingly...